info@seagull-health.com
SeagullHealth
语言:
search

Ziihera(Zanidatamab) Side Effects

This section details the adverse reactions associated with ZIIHERA treatment.

Adverse Reaction Profile

The most frequently reported adverse reactions include diarrhea, infusion-related reactions, abdominal pain, and fatigue. Laboratory abnormalities such as decreased hemoglobin, lymphocytes, and elevated liver enzymes are also common. Serious adverse reactions can occur, including biliary obstruction, infections, and pneumonitis. Dose interruptions, reductions, or permanent discontinuation may be necessary based on the severity and recurrence of these events.

Zanidatamab(Ziihera)
Zanidatamab(Ziihera)
Treatment of previously treated, unresectable or metastatic HER2-positive (IHC...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved